Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

114 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A phase I trial of vatalanib (PTK/ZK) in combination with bevacizumab in patients with refractory and/or advanced malignancies.
Jones SF, Spigel DR, Yardley DA, Thompson DF, Burris HA 3rd. Jones SF, et al. Clin Adv Hematol Oncol. 2011 Nov;9(11):845-52. Clin Adv Hematol Oncol. 2011. PMID: 22252616 Clinical Trial.
Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer. Aromasin Study Group.
Jones S, Vogel C, Arkhipov A, Fehrenbacher L, Eisenberg P, Cooper B, Honig S, Polli A, Whaley F, di Salle E, Tiffany J, Consonni A, Miller L. Jones S, et al. J Clin Oncol. 1999 Nov;17(11):3418-25. doi: 10.1200/JCO.1999.17.11.3418. J Clin Oncol. 1999. PMID: 10550136 Clinical Trial.
Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies.
Jones S, Hainsworth J, Burris HA 3rd, Thompson D, Raefsky E, Johnson V, Calvert S, Bulanhagui C, Lebwohl D, Greco FA. Jones S, et al. Invest New Drugs. 2002 Feb;20(1):55-61. doi: 10.1023/a:1014473930546. Invest New Drugs. 2002. PMID: 12008664 Clinical Trial.
A phase I trial of weekly paclitaxel plus prolonged oral eniluracil/5-fluorouracil in patients with refractory malignancies.
Jones SF, Greco FA, Hainsworth JD, Patton JW, Barton JH, Willcutt NT, Baker MN, McGuirt PV, Levin J, Burris HA 3rd. Jones SF, et al. Oncologist. 2002;7(5):444-50. doi: 10.1634/theoncologist.7-5-444. Oncologist. 2002. PMID: 12401907 Clinical Trial.
Phase I. Trial of irinotecan plus carboplatin in two dose schedules.
Jones SF, Burris HA 3rd, Hainsworth JD, Yardley DA, Raefsky EA, Miranda FT, Kuzur ME, Willcutt NT, White MB, Greco FA. Jones SF, et al. Oncology (Williston Park). 2003 May;17(5 Suppl 5):36-40. Oncology (Williston Park). 2003. PMID: 12800605 Review.
Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.
Jones SF, Gian VG, Greco FA, Miranda FT, Shipley DL, Thompson DS, Hainsworth JD, Toomey MA, Willcutt NT, Burris HA 3rd. Jones SF, et al. Oncology (Williston Park). 2003 May;17(5 Suppl 5):41-5. Oncology (Williston Park). 2003. PMID: 12800606 Clinical Trial.
Gefitinib in the treatment of advanced, refractory non-small-cell lung cancer: results in 124 patients.
Hainsworth JD, Mainwaring MG, Thomas M, Porter LL 3rd, Gian VG, Jones SF, Greco FA. Hainsworth JD, et al. Among authors: jones sf. Clin Lung Cancer. 2003 May;4(6):347-55. doi: 10.3816/clc.2003.n.014. Clin Lung Cancer. 2003. PMID: 14599303
Pharmacy practice issues with targeted therapy for lung cancer.
Jones S. Jones S. Am J Health Syst Pharm. 2003 Dec 15;60(24 Suppl 9):S11-5. doi: 10.1093/ajhp/60.suppl_9.S11. Am J Health Syst Pharm. 2003. PMID: 14717023
Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer.
Burris H 3rd, Yardley D, Jones S, Houston G, Broome C, Thompson D, Greco FA, White M, Hainsworth J. Burris H 3rd, et al. Among authors: jones s. J Clin Oncol. 2004 May 1;22(9):1621-9. doi: 10.1200/JCO.2004.08.065. J Clin Oncol. 2004. PMID: 15117984 Clinical Trial.
A phase I/II study of exisulind in combination with docetaxel/carboplatin in patients with metastatic non-small-cell lung cancer.
Jones SF, Kuhn JG, Greco FA, Raefsky EL, Hainsworth JD, Dickson NR, Thompson DS, Willcutt NT, White MB, Burris HA 3rd. Jones SF, et al. Clin Lung Cancer. 2005 May;6(6):361-6. doi: 10.3816/clc.2005.n.016. Clin Lung Cancer. 2005. PMID: 15943897 Clinical Trial.
114 results
Jump to page